3.11
Schlusskurs vom Vortag:
$3.18
Offen:
$3.14
24-Stunden-Volumen:
38,071
Relative Volume:
0.20
Marktkapitalisierung:
$75.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.58%
1M Leistung:
+3.32%
6M Leistung:
-29.16%
1J Leistung:
-72.67%
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Firmenname
Artiva Biotherapeutics Inc
Sektor
Branche
Telefon
(858) 267-4467
Adresse
5505 MOREHOUSE DRIVE, SAN DIEGO
Vergleichen Sie ARTV mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ARTV
Artiva Biotherapeutics Inc
|
3.11 | 75.28M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-11 | Fortgesetzt | H.C. Wainwright | Buy |
2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
2024-08-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
2024-08-13 | Eingeleitet | Jefferies | Buy |
2024-08-13 | Eingeleitet | Needham | Buy |
2024-08-13 | Eingeleitet | TD Cowen | Buy |
2024-08-13 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Artiva Biotherapeutics Inc Aktie (ARTV) Neueste Nachrichten
Will Artiva Biotherapeutics Inc. benefit from rate cutsJuly 2025 Institutional & Reliable Price Action Trade Plans - khodrobank.com
How to build a custom watchlist for Artiva Biotherapeutics Inc.Trade Analysis Report & Momentum Based Trading Ideas - Newser
How moving averages guide Artiva Biotherapeutics Inc. tradingTrade Volume Report & Real-Time Sentiment Analysis - Newser
Can Artiva Biotherapeutics Inc. stock outperform in a bear market2025 Earnings Surprises & Technical Analysis for Trade Confirmation - khodrobank.com
Candlestick signals on Artiva Biotherapeutics Inc. stock todayPortfolio Risk Report & High Return Trade Opportunity Guides - Newser
Real time scanner hits for Artiva Biotherapeutics Inc. explainedQuarterly Portfolio Summary & Proven Capital Preservation Tips - Newser
Backtesting results for Artiva Biotherapeutics Inc. trading strategies2025 Market Overview & Smart Allocation Stock Reports - Newser
Can Artiva Biotherapeutics Inc. hit a new high this month2025 Biggest Moves & Trade Opportunity Analysis Reports - Newser
Analyzing drawdowns of Artiva Biotherapeutics Inc. with statistical toolsJuly 2025 Levels & Low Risk Entry Point Guides - Newser
Will Artiva Biotherapeutics Inc. see short term momentum2025 Top Gainers & High Conviction Buy Zone Alerts - Newser
Applying Wyckoff theory to Artiva Biotherapeutics Inc. stockQuarterly Market Summary & Expert Approved Momentum Ideas - Newser
Artiva Biotherapeutics Inc. stock trendline breakdownWeekly Stock Recap & Daily Oversold Bounce Ideas - Newser
Risk vs reward if holding onto Artiva Biotherapeutics Inc.Market Sentiment Report & Reliable Price Action Trade Plans - Newser
Using Python tools to backtest Artiva Biotherapeutics Inc. strategies2025 Risk Factors & AI Powered Market Entry Strategies - Newser
Can Artiva Biotherapeutics Inc. deliver consistent dividendsWeekly Trend Report & Community Consensus Trade Signals - khodrobank.com
Does Artiva Biotherapeutics Inc. stock have upside surprise potential2025 Macro Impact & Safe Swing Trade Setup Alerts - khodrobank.com
Leading vs lagging indicators on Artiva Biotherapeutics Inc. performance2025 Buyback Activity & Fast Gain Stock Trading Tips - Newser
Using data filters to optimize entry into Artiva Biotherapeutics Inc.Trade Exit Report & Community Consensus Picks - Newser
Historical volatility pattern of Artiva Biotherapeutics Inc. visualizedJuly 2025 Catalysts & Growth Focused Entry Point Reports - Newser
Is Artiva Biotherapeutics Inc. forming a bottoming base2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - Newser
What’s the beta of Artiva Biotherapeutics Inc. stockJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - khodrobank.com
Risk Recap: Is Artiva Biotherapeutics Inc. a top pick in the sectorWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - khodrobank.com
Will Artiva Biotherapeutics Inc. outperform its industry peersTrade Volume Report & Pattern Based Trade Signal System - khodrobank.com
Predicting Artiva Biotherapeutics Inc. trend using moving averages2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser
Can Artiva Biotherapeutics Inc. sustain earnings growthJuly 2025 Patterns & Reliable Intraday Trade Alerts - khodrobank.com
Is a relief rally coming for Artiva Biotherapeutics Inc. holdersJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Sector ETF performance correlation with Artiva Biotherapeutics IncMarket Growth Summary & AI Driven Stock Movement Reports - Newser
Sector ETF performance correlation with Artiva Biotherapeutics Inc.Weekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
Will Artiva Biotherapeutics Inc. benefit from macro trends2025 Top Gainers & Safe Entry Momentum Tips - Newser
Artiva Biotherapeutics Inc. recovery potential after sell offJuly 2025 Earnings & Reliable Entry Point Alerts - Newser
How to use Fibonacci retracement on Artiva Biotherapeutics Inc.2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser
How institutional ownership impacts Artiva Biotherapeutics Inc. stockJuly 2025 Macro Moves & Entry Point Confirmation Signals - Newser
Detecting support and resistance levels for Artiva Biotherapeutics Inc.Portfolio Gains Report & Safe Swing Trade Setups - Newser
Finanzdaten der Artiva Biotherapeutics Inc-Aktie (ARTV)
Es liegen keine Finanzdaten für Artiva Biotherapeutics Inc (ARTV) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):